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Abstract. The aim of the research was to study the effectiveness of the utilization of the 
enterosorbent drug Micofix® Plus in the mixed fodder for young pigs depending on their weight 
increase, fodder intake and haematological parameters. The research was conducted on pigs of 
Landrace breed from 09.07 to 09.10.2010 at the State Scientific and Production Enterprise for Pig 
Breeding and Hybridisation “Moldsuinhibrid”. In order to carry out the trial on the principle of 
analogy, 40 breeding pigs were selected, which were then divided into four groups of ten heads each. 
The feeding of the animals in the trial was similar n all groups, the differences was that the piglets in 
the groups Eg1, EG2, EG3 were fed with a mixed fodder to which the adsorbent Mycofix ® Plus at the 
level of 1.0, 1.5 and 2.0 kg/t respectively was added, in comparison with the control group (CG) in 
which the pigs were fed with the basic fodder. It was established, that under the influence of the test d 
adsorbent at the end of the trial the live weight of he animals in Eg1, EG2, EG3 exceeded the live 
weight of the pigs in the CG by 0.93, 2.05 and 1.38 kg or 0.96, 2.11 and 1.42% (on the basis of 
statistically unreliable data). The introduction of the drug Mycofix ® Plus at the level of 1.5 kg/t in the 
diets for young pigs was the most effective, and helped to reduce the fodder intake by 2.28%. Blood 
haematological analysis testified that when the fodder was supplemented with Mycofix ® Plus the 
basic indicators were all in the normal physiological range. 
 




One of the priorities of the livestock-breeding inte sification is to find effective ways 
to improve animal productivity and the quality of livestock products. 
In this regard, the problem of mycotoxicosis is of great importance for many pig 
farms. The main danger lies in the fact, that the poisoning could occur in a latent form, and 
manifest itself in the form of reduced productivity and increased level of morbidity. 
At present, as a rule, the toxicological study of fodders tries to determine the level of 
the mycotoxins, which is considered to be most significant in terms of its impact on the health 
and productivity of animals and birds. 
Mycotoxins are toxic metabolites of the secondary synthesis of fungi (moulds). They 
form a group of hundreds of chemically diverse toxic components (William, 1989; Moss, 
1996; Rotter et al., 1996, Sweeney and Dobson, 1998). The most common mycotoxins are 
aflatoxins, ochratoxin A, trichothecenes, zearalenone and fumonisins. 
Mycotoxins reduce fodder intake, and cause damage to the cells of gastrointestinal 





They can easily be absorbed (fall) by the blood. Then, using the system of blood vessels, they 
may spread throughout the body and destroy the internal organs such as the brain, 
reproductive system, liver and kidneys. Therefore, th y may cause the deterioration of the 
animal health, the reduction of reproduction and growth rates, the reduction of the level of fat-
soluble vitamins in fodders, which in its turn can cause diseases with different clinical 
manifestations depending on the nature of the toxin, its amount, duration of exposure, type of 
microorganism, its age and diet (Bonomi et al., 1995; Maxwell and Lip, 1997). 
In addition, the fodder which has been contaminated with mycotoxins can lead to 
other consequences, such as feed refusal, a high feed conversion, reduced gains, increased 
morbidity due to the immune suppression and the intrac ion with the reproductive functions 
(CAST, 1989; Lindenmann et al., 1993; Kubena et al., 1998), which cause huge economic 
losses. 
To avoid mycotoxicosis, certain strategies have been developed (Doyle t al., 1982; 
Park, 1993; Bauer, 1994; Ramos and Hernandez, 1997), which can be divided into methods 
before and after the harvest. 
The problem of mycotoxicosis is relevant to many pig farms. In order to improve the 
protection of animals against mycotoxins new adsorbents are currently offered. Their 
composition includes yeast culture, Beta-glucans and probiotics. 
 
MATERIALS AND METHODS 
 
To conduct the scientific and production trial using the analogy principle, taking into 
account the breed, origin, age, body weight, sex and power of growth of the animals, forty 
breeding pigs were selected (Ovsyannikov, 1976), which were then divided into four groups 





Group Number of animals in each group Feeding featur s 
CG 10 BMF (basic mixed fodder) 
EG1 10 BMF +  1.0 kg/t Mycofix® Plus* 
EG2 10 BMF +  1.5 kg/t Mycofix® Plus 
EG3 10 BMF +  2.0 kg/t Mycofix® Plus 
* Note: The preparation Micofyx® Plus (BIOMIN) effectively fights with non-absorbable mycotoxins such as 
trichothecenes (T2-toxin, DON), and also with poorly adsorbed estrogen mycotoxin zearalenone that violate the 
animals’ reproductive function (http://piginfo.ru/shop/detail . php? ID = 7744). 
Used for piglets and breeding pigs – 1.5-2.5 kg/t of prepared fodder (as recommended by the manufacturer 
«BIOMIN»; http://biocom.by/additives.neutralizers.10 aspx). 
 
The feeding of the animals in the trial was carried out using mixed fodder, and was 
similar in all groups. The only difference was, that the main fodder for the pigs in EG1, EG2, 
EG3 - experimental groups - was supplemented with the adsorbent Mycofix® Plus at different 
levels. 
The mixed fodder was prepared using local feedstuffs, talking into account the pigs’ 
age features, and the changes in their body weight (Tab. 2). 
The concentration of nutrients in the mixed fodder (Tab. 3) corresponded to the 
regulatory requirements (Kalashnikov et al., 2003). 





Таb. 2                                                                                        





Maize grain 30.6 21.0 
Wheat 17 - 
Wheat bran - - 
Barley grain 26 48.8 
Soybean meal 18.1 16.3 
Sunflower meal - 4.7 
Fish meal 3.5 2.5 









Nutritious units oats 1.20 1.13 
Exchange energy, MJ 11.39 12.74 
Crude protein, g 185.39 180.74 
Digestible protein, g 155.10 149.29 
Crude fibre, g 38.48 48.06 
Lysine, g 9.02 8.66 
Methionine + cystine, g 5.64 5.69 
Salt, g 0.35 0.35 
Calcium, g 7.05 8.59 
Phosphorus, g 5,14 5.13 
Iron, mg 154.30 135.21 
Copper, mg 6.31 6.31 
Zinc, mg 33.50 34.44 
Manganese, mg 19.65 15.47 
Cobalt, mg 0.14 0.17 
Iodine, mg 0.19 0.23 
Vitamin A, thousand IU 2.42 2.40 
Vitamin D, thousand IU  0.67 0.46 
Vitamin E, thousand IU  0.81 0.97 
B1 (thiamine), mg 22.49 30.15 
B2 (riboflavin), mg 3.93 3.72 
B3 (pantothenic acid), mg 1.72 1.55 
B4 (choline), mg 9.35 9.22 
B5 (nicotinic acid), mg 1052.93 1146.90 
B12 (cyanocobalamine), mg 42.61 53.60 
Premix 2231 2.5 2.0 
Soybean oil - 3.0 






Throughout the trial the animals were fed three times a day. During the research 
period a daily record of the fodder consumed by the pigs in each group was kept by weighing 
the fodder given to the animals, and the leftovers collected after the feeding. 
The experimental animals in each experimental group were kept in special boxes of 
BPS-2 type. At the beginning of the preparatory andccounting periods, and at the end of 
each trial period an individual weighing of the piglets was conducted. 
To study the state of the pigs, blood samples were tak n at the beginning and the end 
of the trial. The morphological and biochemical blood analysis was carried out at the 
Republican Diagnostic Centre. At the beginning of the preparatory period, the beginning of 
the trial, during the periods of growth and at the end of the trial the record of the change in 
body weight was performed, by weighing each pig individually. 
The data obtained in the scientific and production rial were processed statistically 
(Plohinsky, 1969) using the computer program EXCEL. 
 
RESULTS AND DISCUSSIONS 
 
The research on the effectiveness of the drug Mycofix ® Plus introduced in the 
fodder for young pigs were carried out at the State Scientific and Production Enterprise for 
Pig Breeding and Hybridisation “Moldsuinhibrid” in the period from 09.07 to 09.10.2010. 
The data obtained as a result of the individual weighing of the pigs showed (Tab. 4), 
that at the end of the first trial period under theinfluence of the drug Mycofix® Plus the 
weight of the pigs in the experimental groups EG1, EG2, EG3 increased in comparison with 
the CG by 0.86%, 7.12% and 0.39%, i.e. the pigs which received the drug at the level of 1.5 
kg/t had the highest weigh. 
Таb. 4 
Live weight of the pigs by the trial periods 
 










 At the 
beginning of 
the preparatory 






period of the 
trial 
At the end of 
the first period 
of the trial 
At the end of 
the second 
period of the 
trial 
At the end of 
the trial 
X ± Sx 10.80 ± 0.054 14.22 ± 0.076 24.49 ± 0.673 35.12 ± 0.693 97.25 ± 3.243 
S ± Ss 0.170 ± 0.038 0.240 ± 0.054 2.128 ± 0.476 2.192 ± 0.490 10.254 ± 2.293 CG 
V,% ±Sv, % 1.574 ± 0.352 1.691 ± 0.378 8.692 ± 1.943 6.241 ± 1.396 10.544 ± 2.358 
X ± Sx 10.54 ± 0.138 14.31 ± 0.114 24.70 ± 0.114 35.32 ± 1.045 98.18 ± 2.025 
S ± Ss 0.437 ± 0.098 0.360 ± 0.081 2.353 ± 0.526 3.306 ± 0.739 6.405 ± 1.432 EG1 
V,% ± Sv, % 4.150 ± 0.928 2.518 ± 0.563 9.528 ± 2.130 9.361± 2.093 6.524 ± 1.459 
X ±Sx 10.79 ± 0.098 14.48 ± 0.105 26.23 ± 1.037 38.54 ± 1.978 99.30 ± 3.336 
S ±Ss 0.311 ± 0.069 0.331 ± 0.074 3.280 ± 0.733 6.254 ± 1.399 10.549 ± 2.359 EG2 
V,%±Sv, % 2.880 ± 0.644 2.287± 0.511 12.506 ± 2.796 16.228 ± 3.629 10.624 ± 2.376 
X ± Sx 10.75 ± 0.127 14.26 ± 0.138 24.58 ± 0.550 36.27 ± 0.755 98.63 ± 2.311 
S ± Ss 0.401 ± 0.090 0.437± 0.098 1.738 ± 0.389 2.388 ± 0.534 7.307 ± 1.634 EG3 
V,% ± Sv, % 3.736 ± 0.835 2.287± 0.686 7.072 ± 1.58 6.585 ± 1.472 7.409 ± 1.657 
 
At the end of the second trial period the difference between the control group (35.12 
kg) and EG2 (38.54 kg of live weight) was of 9.74%, and between the CG and EG1, EG3 it 





had a positive impact on the growth rate of the piglets. At the end of the trial the same trend in 
the experimental groups was observed –the greatest liv  weight of pigs was in group EG2-
99.3 kg as a whole for the trial, which was higher than in the control group by 2.11% (on the 













Fig.1. Average daily gains by trial periods 
 
The average daily live weight gain of the pigs by periods, as a whole for the trial, 
was higher in the experimental groups, and at the end of the trial in EG1, EG2, EG3 it was of 
0.612, 0.616 and 0.628 kg respectively, i.e. by 1.01, 3.67, and 1.61% higher than i  the CG  
(Fig. 1). On the basis of the data on the amount of the consumed fodder and the leftovers, the 
fodder intake was calculated by trial periods, as a whole for the trial and on the average by
one pig per day.  
Таb. 5 













526.71 469.26 477.53 477.35 
Fodder intake during: 
I period 
II period 
III period 2198.56 2186.54 2184.79 2190.94 
 
The analyses of the data on the fodder intake by the pigs as a whole for the trial (Tab. 
5, fig. 2, 3) showed that under the influence of different levels of enterosorbent i  was lower in 
all experimental groups compared with the CG, by 2.28% in EG1 and EG2 and by 1.83% in 





















Fig. 3. The amount consumed on the average by one pig, kg/day 
                     
 
Fodder intake per kilogram of live weight gain during the whole trial was also lower 















Fig. 4. The feed consumption per unit of live weight of piglets, kg 
 
 
To compare the characteristics of the intensity of metabolic processes in the body 
and the health of the experimental animals under th influence of different levels of the 
preparation Mycofix® Plus, at the beginning and theend of the trial, blood samples were 
collected from three pigs in each group, in order to perform a morphological and biochemical 
analysis. The number of erythrocytes and leukocytes, the level of haemoglobin, WBC and 
other options were determined. 
The obtained data showed, that the physiological rectivity of the animals in all 
groups at the beginning of the trial was approximately equal (Tab. 6).  
At the end of the trial under the influence of the drug Mycofix® a tendency towards 
the increase of red blood cells was observed in EG2and EG3 in comparison with the CG and 
EG1 by 0.42 and 0.61 x 1012/L, and by 0.21 and 0.40 x 1012/L respectively, which was an 











Morphological parameters of the pigs’ blood at the beginning of the trial, X ± Sx 
 
Indices CG EG1 EG2 EG3 
Red blood cells (RBC), 
x 1012/L 6.96±0.296 6.90±0.200 6.63±0.145 7.43±0.809 
Hemoglobin, g/L 107.33±2.603 100.66±2.906 100.35±1.48 110.33±8.950 
Color index, un. 0.46±0.026 0.43±0.023 0.42±0.000 0.44±0.019 




4.00±1.155 3.33±1.333 4.00±1.155 4.00±0.577 
Leukocytes, White 
blood cells (WBC),  
x 109/L 
27.56±2.245 29.53±0.845 17.50±1.361 19.93±5.157 
Leukocytes stab, x 
109/L 8.00±1.000 10.00±1.155 7.66±1.453 9.33±1.453 
Leukocytes segmented, 
x 109/L 36.66±2.404 36.00±2.000 29.66±4.631 28.66±6.360 
Eosinophils, x 109/L 1.00±0.000 2.33±0.667 1.00±0.000 3.33±0.333 
Monocytes, x 109/L 3.00±0.557 2.00±0.577 2.33±0.333 2.00±0.577 




Morphological parameters of blood at the end of the trial, X ± Sx 
 
Indices CG EG1 EG2 EG3 
Hematocrit, L/L   0.50±0.02 0.48±0.01 0.52±0.05 0.46±0.01 
Average volume of red blood 
cells, fl  60.03±1.431 59.70±1.732 60.23±0.418 61.30±1.229 
Average content of haemoglobin 
in an erythrocyte, pg 16.97±0.12 16.80±0.83 17.20±0.52 17.63±0.47 
Average concentration of 
haemoglobin in an erythrocyte, 
g/L 
283.00±5.568 281.00±6.506 285.66±7.055 287.33±2.028 
Leucocytes, White blood cells 
(WBC), x 109/L 
21.47±4.53 21.53±1.39 19.00±2.13 20.33±1.07 
Lymphocytes, % 0.56±0.018 0.58±0.052 0.59±0.027 0.58±0.005 
Neutrophils, % 0.45±0.005 0.40±0.044 0.39±0.035 0.39±0.014 
Lymphocytes, x 109/L 14.06±1.330 12.63±1.989 11.26±1.097 11.80±0.603 
Neutrophils, x 109/L 10.30±2.078 8.53±0.491 7.60±1.320 7.93±0.176 
Width of red blood cells spread, fl  36.13±1.146 38.43±0.260 38.36±1.415 36.33±0.639 
Width of the platelets spread, fl  12.96±0.233 14.10±0.723 13.96±0.393 12.96±0.606 




















Fig. 5. The level of red blood cells in the pigs’ blood at the end of the trial, g/l 
 
The data obtained after the biochemical analysis of the pigs’ blood at the end of the 
trial suggested, that the supplementation of the fodder with the prepa ation enterosorbent 
affected the increase of the albumin content in the animals’ blood in the experimental groups 
compared to the control group by10.15% 1.86 % and 7.37% respectively. The increase of the 
albumin level in the piglets in EG1 caused the greatest anabolic effect, because the growth 
energy in this group was the highest (Tab.8, fig.6). 
Таb. 8   
Biochemical parameters of the blood at the nd of the trial, X ± Sx 
 
Indices CG EG1 EG2 EG3 
Total protein, g / l 74.56±4.967 71.16±4.506 72.63±2.739 66.76±3.472 
α1-globulins,% 6.90±0.462 7.33±0.769 7.53±0.348 6.20±1. 97 
α2-globulin,% 27.93±2.199 28.56±1.571 29.56±1.132 29.60±1.997 
β-globulins,% 16.60±1.069 14.93±1.068 14.16±0.606 15.23±1.690 
γ-globulins,% 14.10±1.747 11.20±0.929 13.30±2.303 11.96±1.281 
Aspartate 
aminotransferase, U/L 
113.66±23.483 109.66±41.281 146.66±48.499 81.00±3.215 
A/G, A/G 0.52±0.060 0.61±0.046 0.54±0.073 0.58±0.084 
Calcium, mmol/L 3.08±0.152 3.42±0.201 4.12±0.152 2.81±0.329 
Phosphorus, mmol/L 2.01±0.474 2.61±0.164 2.43±0.502 1.98±0.193 
 
At the end of the trial the animals in groups EG1 and EG2 had the highest level of 
alanine aminotransferase (91.66 and 90.33 U/L compared with CG-67.33 U/L), which 





Fig. 6. The level of the albumin content in the pigs’ blood at the nd of the trial, g/L 
 
Fig. 7. The level of ALT  in the pigs’ blood at the nd of the trial, U/L 
 
The activity of the alkaline phosphatase at the end of the trial (Fig. 8) was higher in 
the experimental groups compared to the control group. It is known that the alkaline 
phosphatase is involved in the metabolism of phosphoric acid, splitting it from the organic 














Fig. 8. Activity of the alkaline phosphatase in thepigs’ blood at the end of the trial, U/L 
 
This pointed to the fact that under the influence of the studied preparation the content 




The utilization of the Mycofix® Plus preparation in the fodder for breeding pigs has 
a positive effect on the dynamics of the pigs’ live weight. It was determined that the weight of 
the young pigs which received fodder supplemented with the adsorbent u der study, was 
greater to the nd of the trial in comparison with the pigs in thecontrol group by 0.93–2.05 kg 
or 0.95–2.11% (on the basis of statistically unreliable data). 
The supplementation with the Mycofix® Plus of the fodder for pigs at the level of 
1.5 kg/t was the most effective. 
The introduction of drug Mycofix® Plus at the level of 1.5 kg/t in the diets for young 





The haematological analysis testified that when adding the Mycofix® Plus to the 
fodder for pigs the basic indicators were all in the normal physiological range. 
The utilization of the drug Mycofix® Plus in the fodder for growing piglets yields a 
conditional economic income of 26.49 and 19.73 lei per head in EG2 and EG3 respectively. 
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